Joel Thompson
Biotech strategist creating therapies to help fewer people go blind. VP of Strategy at Tavo; previously McKinsey, Neurolens, and startup operations.
Building Tavo5 LINKS
- Tavo BiotherapeuticsExplore our work on new therapies for glaucoma and retinal disease.↗
- Tavo’s $17M Series ARead how new financing is advancing both vision-saving programs.↗
- Why I’m building TavoRead my perspective on Tavo’s mission and the team behind it.↗
- Joining Tavo’s leadership teamRead how my ophthalmology and strategy experience led to Tavo.↗
- Winning Pitch mentorshipSee the ophthalmology founders and mentors shaping emerging companies.↗
Earlier Work4 LINKS
- My career pathRead how startups, venture investing, Stern, and McKinsey shaped me.↗
- Neurolens technologyLearn about the vision technology I helped build and commercialize.↗
- Fernson Brewing CompanyExplore the craft brewery I previously helped lead and scale.↗
- Building the Fernson businessRead lessons from growing a regional consumer brand.↗